Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 16250301000001116 | Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| 16250401000001112 | Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| 58209701000001118 | Lanoxin PG 62.5microgram tablets (GlaxoSmithKline UK Ltd) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| 58860301000001119 | Lanoxin PG 62.5microgram tablets (Aspen Europe GmbH) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| 69178401000001113 | Lanoxin PG 62.5microgram tablets (Aspen Pharma Trading Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) 500 tablet | Is pack of | False | Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) | Inferred relationship | Existential restriction modifier | |
| Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) 500 tablet | Has AMP | True | Lanoxin PG 62.5microgram tablets (GlaxoSmithKline) | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets